Autres langues Q32 Bio Inc.

Actions

QTTB

US7469641051

Marché Fermé - Nasdaq Autres places de cotation 22:00:00 26/04/2024			Varia. 5j.	Varia. 1 janv.
28,02 ^USD	-0,78 %		+24,59 %	+156,03 %

11/04	Q32 BIO INC. : Opinion positive de Oppenheimer	ZM
02/04	Q32 BIO INC. : Piper Sandler relève son opinion	ZM

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Q32 Bio Appoints Lee Kalowski as President & Chief Financial Officer	03/04
Q32 Bio Inc. Appoints Lee Kalowski as Chief Financial Officer	03/04
Q32 Bio Inc.(NasdaqGM:QTTB) added to NASDAQ Composite Index	26/03
Homology Medicines, Inc.(NasdaqGS:FIXX) dropped from NASDAQ Composite Index	25/03
Q32 Bio Inc. announced that it has received $42 million in funding from a group of investors	25/03
Q32 Bio Inc. completed the acquisition of Homology Medicines, Inc. from 5AM Venture Management, LLC, Arch Venture Fund VIII, L.P. and ARCH Venture Fund VIII Overage, L.P. managed by Arch Venture Partners, L.P., Pfizer Inc. and TLS Beta Pte. Ltd. in a reverse merger transaction.	25/03
North American Morning Briefing : Markets on Hold -2-	20/03
Homology Medicines Declares Distribution to Common Stockholders	18/03
Homology Medicines, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	13/03
HOMOLOGY MEDICINES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Homology Medicines, Inc. - FIXX	27/02
Neurogene Names Julie Jordan as Chief Medical Officer	16/01
Homology Medicines Receives NASDAQ Notification Regarding Minimum Bid Price Deficiency	03/01
HOMOLOGY MEDICINES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Homology Medicines, Inc. - FIXX	18/11
FIXX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Homology Medicines, Inc. Is Fair to Shareholders	16/11
Q32 Bio and Homology Medicines Announce Merger Agreement	16/11
Q32 Bio and Homology Medicines Announce Merger Agreement	16/11
Q32 Bio Inc. announced that it expects to receive $42 million in funding from a group of investors	16/11
Homology Medicines: Q3 Earnings Snapshot	14/11
Homology Medicines Reports Third Quarter 2023 Financial Results	14/11
Homology Medicines, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	14/11

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Q32 Bio Inc.

Actions

QTTB

US7469641051

Autres langues

Filtres